BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22538810)

  • 1. Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor.
    Hanyu R; Wehbi VL; Hayata T; Moriya S; Feinstein TN; Ezura Y; Nagao M; Saita Y; Hemmi H; Notomi T; Nakamoto T; Schipani E; Takeda S; Kaneko K; Kurosawa H; Karsenty G; Kronenberg HM; Vilardaga JP; Noda M
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7433-8. PubMed ID: 22538810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone.
    Tamasi JA; Vasilov A; Shimizu E; Benton N; Johnson J; Bitel CL; Morrison N; Partridge NC
    J Bone Miner Res; 2013 Sep; 28(9):1975-86. PubMed ID: 23519994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
    Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
    J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
    Bedi B; Li JY; Tawfeek H; Baek KH; Adams J; Vangara SS; Chang MK; Kneissel M; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E725-33. PubMed ID: 22393015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.
    Novince CM; Michalski MN; Koh AJ; Sinder BP; Entezami P; Eber MR; Pettway GJ; Rosol TJ; Wronski TJ; Kozloff KM; McCauley LK
    J Bone Miner Res; 2012 Jan; 27(1):11-25. PubMed ID: 21932346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone induces bone formation in phosphorylation-deficient PTHR1 knockin mice.
    Datta NS; Samra TA; Abou-Samra AB
    Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1183-8. PubMed ID: 22338074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
    Clifton KB; Conover CA
    Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.
    Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG
    Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice.
    Gray SK; McGee-Lawrence ME; Sanders JL; Condon KW; Tsai CJ; Donahue SW
    Bone; 2012 Sep; 51(3):578-85. PubMed ID: 22584007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotoxicosis Involves β2-Adrenoceptor Signaling to Negatively Affect Microarchitecture and Biomechanical Properties of the Femur.
    Neofiti-Papi B; Albuquerque RP; Miranda-Rodrigues M; Gonçalves NJN; Jorgetti V; Brum PC; Ferreira JCB; Gouveia CHA
    Thyroid; 2019 Aug; 29(8):1060-1072. PubMed ID: 31264512
    [No Abstract]   [Full Text] [Related]  

  • 17. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
    Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR
    Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ixazomib enhances parathyroid hormone-induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor.
    Yang Y; Lei H; Qiang YW; Wang B
    Mol Biol Cell; 2017 Jul; 28(13):1792-1803. PubMed ID: 28495797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
    J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.